Wed, Oct 22, 2014, 8:45 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Regeneron Pharmaceuticals, Inc. Message Board

  • bearmlp Aug 17, 2014 5:26 PM Flag

    Speaking of Sanofi

    Sanofi may also buy out MNKD who they just partnered with for their recently approved fast acting inhaled insulin drug “Afrezza”, Now, given the potential blockbuster potential of this drug you would think that of all people, Regeneron employees and stock holders might understand what may lay ahead. 385 million diabetics worldwide but 3 times the market for pre-diabetics, which is in play! I would think given the low price currently for MNKD, it would be worth investigating. Remember, well, how could we forget that when Regeneron, got approved it basically went nowhere, then just 4 months after FDA approval, initial sell in figures came in and you know what happened. Once sell n revenues are reported from the field that's all we need to know!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
384.46+3.45(+0.91%)Oct 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yelp, Inc.
NYSEWed, Oct 22, 2014 4:00 PM EDT
NXP Semiconductors NV
NasdaqGSWed, Oct 22, 2014 4:00 PM EDT
ServiceNow, Inc.
NYSEWed, Oct 22, 2014 4:01 PM EDT